EV/EBITDA
-1.86
+0.07+3.63%
24 min ago
Summary
- As of February 7, 2025, NTLA EV/EBITDA is -1.86, with a rise of +0.07 (+3.63%) during the most recent trading day.
- Over the past year, NTLA EV/EBITDA has increased by +2.75 (+59.65%).
- NTLA EV/EBITDA is now -4.49% below its all-time high of -1.78.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.6% | -3.6% | -3.5% |
| 1 m1 month | +23.5% | -23.5% | -23.1% |
| 3 m3 months | +39.4% | -39.4% | -38.9% |
| 6 m6 months | +55.5% | -54.3% | -54.1% |
| ytdytd | +15.8% | -15.9% | -15.6% |
| 1 y1 year | +59.6% | -57.9% | -62.6% |
| 5 y5 years | +70.9% | +52.3% | -27.8% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.5% | -2.43 | +23.5% | |
| 3 m | 3-month | -1.78 | -4.5% | -3.35 | +44.5% |
| 6 m | 6-month | -1.78 | -4.5% | -4.65 | +60.0% |
| 1 y | 1-year | -1.78 | -4.5% | -6.05 | +69.3% |
| 3 y | 3-year | -1.78 | -4.5% | -28.10 | +93.4% |
| 5 y | 5-year | -1.78 | -4.5% | -72.04 | +97.4% |
| alltime | all time | -1.78 | -4.5% | -72.04 | +97.4% |
Intellia Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.86(-15.8%) |
| 2024 | -2.21(-59.2%) |
| 2023 | -5.42(-7.7%) |
| 2022 | -5.87(-82.5%) |
| 2021 | -33.56(+25.6%) |
| Date | Value |
|---|---|
| 2020 | -26.73(+286.3%) |
| 2019 | -6.92(+11.6%) |
| 2018 | -6.20(-12.9%) |
| 2017 | -7.12(+11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics EV/EBITDA year-on-year change?
What is Intellia Therapeutics EV/EBITDA?
The current EV/EBITDA of NTLA is -1.86
What is the all time high EV/EBITDA for Intellia Therapeutics?
Intellia Therapeutics all-time high EV/EBITDA is -1.78
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics EV/EBITDA has changed by +0.35 (+15.84%) since the beginning of the year
What is Intellia Therapeutics EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +2.75 (+59.65%)